Abstract:Objective. Fetal growth restriction (FGR) is a significant contributor to negative pregnancy and postnatal developmental outcomes. Currently, the exact pathological mechanism of FGR remains unknown. This study aims to utilize multiomics sequencing technology to investigate potential relationships among mRNA, gut microbiota, and metabolism in order to establish a theoretical foundation for diagnosing and understanding the molecular mechanisms underlying FGR. Methods. In this study, 11 healthy pregnant women and nine pregnant women with FGR were divided into Control group and FGR group based on the health status. Umbilical cord blood, maternal serum, feces, and placental tissue samples were collected during delivery. RNA sequencing, 16S rRNA sequencing, and metabolomics methods were applied to analyze changes in umbilical cord blood circulating mRNA, fecal microbiota, and metabolites. RT-qPCR, ELISA, or western blot were used to detect the expression of top 5 differential circulating mRNA in neonatal cord blood, maternal serum, or placental tissue samples. Correlation between differential circulating mRNA, microbiota, and metabolites was analyzed by the Spearman coefficient. Results. The top 5 mRNA genes in FGR were altered with the downregulation of TRIM34, DEFA3, DEFA1B, DEFA1, and QPC, and the upregulation of CHPT1, SMOX, FAM83A, GDF15, and NAPG in newborn umbilical cord blood, maternal serum, and placental tissue. The abundance of Bacteroides, Akkermansia, Eubacterium_coprostanoligenes_group, Phascolarctobacterium, Parasutterella, Odoribacter, Lachnospiraceae_UCG_010, and Dielma were significantly enriched in the FGR group. Metabolites such as aspartic acid, methionine, alanine, L-tryptophan, 3-methyl-2-oxovalerate, and ketoleucine showed notable functional alterations. Spearman correlation analysis indicated that metabolites like methionine and alanine, microbiota (Tyzzerella), and circulating mRNA (TRIM34, SMOX, FAM83A, NAPG) might play a role as mediators in the communication between the gut and circulatory system interaction in FGR. Conclusion. Metabolites (METHIONINE, alanine) as well as microbiota (Tyzzerella) and circulating mRNA (TRIM34, SMOX, FAM83A, NAPG) were possible mediators that communicated the interaction between the gut and circulatory systems in FGR.

Metabolomic profiling of human feces and plasma from extrauterine growth restriction infants

Characteristics of the Intestinal Microbiota and Metabolism in Infants with Extrauterine Growth Restriction

Gut microbial network signatures of early colonizers in preterm neonates with extrauterine growth restriction

Transgenerational Inheritance Of Genome-Wide Dna Methylation Profiles In Pulmonary Vascular Endothelial Dysfunction Following Extrauterine Growth Restriction

Metabolic Biomarkers of Monochorionic Twins Complicated with Selective Intrauterine Growth Restriction in Cord Plasma and Placental Tissue

Potential Association of Gut Microbial Metabolism and Circulating mRNA Based on Multiomics Sequencing Analysis in Fetal Growth Restriction

Non-targeted Urinary Metabolomics in Pregnancy and Associations with Fetal Growth Restriction.

Can we prevent extrauterine growth restriction by doing metabolic analysis?

Association Between Extrauterine Growth Restriction and Changes of Intestinal Flora in Chinese Preterm Infants.

Investigation of newborn blood metabolomics in varying intrauterine growth conditions

Placental Metabolomics of Fetal Growth Restriction

Metabolic Dynamics and Prediction of Sfgr and Adverse Fetal Outcomes: a Prospective Longitudinal Cohort Study.

Metabolomic Analysis Reveals Differences In Umbilical Vein Plasma Metabolites Between Normal And Growth-Restricted Fetal Pigs During Late Gestation

Non-Targeted Metabolomic Study of Fetal Growth Restriction

Current Epidemiology and Factors Contributing to Extrauterine Growth Restriction in Very Preterm Infants in China

Alterations in the Gut Microbiome and Metabolisms in Pregnancies with Fetal Growth Restriction

Study on the relationship between selective intrauterine growth restriction (sIUGR) and metabolic disorder-Metabonomics Study of cord blood based on gas chromatography time-of-flight mass spectrometry (GC-TOF/MS)

The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing

New Approaches to Fetal Growth Restriction: The Time for Metabolomics Has Come

Extrauterine Growth Restriction in Preterm Infants: Postnatal Growth Pattern and Physical Development Outcomes at Age 3–6 Years

[Risk Factors for Extrauterine Growth Restriction in Preterm Infants with Gestational Age Less Than 34 Weeks].